Generic drugmakers in India are revising pricing plans after Denmark’s Novo Nordisk (NOV: N) slashed costs for its weight-loss injection Wegovy (semaglutide). Companies that had aimed to launch ...
The US regulator has approved Waskyra (etuvetidigene autotemcel), the first gene-correcting therapy for Wiskott-Aldrich ...
The US Food and Drug Administration (FDA) yesterday issued the final guidance, “Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Products, and ...
The US Food and Drug Administration has approved a US-manufactured version of Augmentin XR (amoxicillin-clavulanate potassium) through its new Commissioner’s National Priority Voucher pilot, ...
Swiss pharma giant Novartis’ has announced results showing that one in four patients with hormone receptor-positive, human ...
Headquartered in Antwerp, Belgium, with an additional site in Denmark (Aarhus). The company is developing macrophage-targeted ...
Vinay Prasad, director of the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), ...
The European Commission has approved Roche’s Gazyva/Gazyvaro (obinutuzumab) in combination with mycophenolate mofetil (MMF) ...
Sanegene Bio has raised more than $110 million in a series B round to move its RNAi programs toward registration studies and ...
Ascletis Pharma (HKEX: 1672) has reported positive topline results from a 13-week Phase II study of ASC30, its once-daily oral GLP-1 agonist for obesity. All three doses met the primary endpoint with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback